Cranford, NJ – According to filings with the U.S. Securities and Exchange Commission, Citius Pharmaceuticals is raising $20,000,012.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Myron Holubiak played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Citius Pharmaceuticals

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development.

To learn more about Citius Pharmaceuticals, visit http://www.citiuspharma.com/

Contact:
Myron Holubiak, President and Chief Executive Officer
908-967-6677
myron.holubiak@citiuspharma.com
https://www.linkedin.com/in/myron-holubiak-b7881611/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved